Want to see JP:4202 full AI Analyst Report?
4202 Stock Chart & Stats
¥1445.50
-¥15.00(-1.04%)
At close: 4:00 PM EDT
¥1445.50
-¥15.00(-1.04%)
Day’s Range― - ―
52-Week Range¥1,112.50 - ¥1,658.00
Previous CloseN/A
Volume648.10K
Average Volume (3M)536.76K
Market Cap
¥373.57B
Enterprise Value¥603.36K
Total Cash (Recent Filing)¥73.03B
Total Debt (Recent Filing)¥310.77B
Price to Earnings (P/E)37.5
Beta0.95
Next Earnings
Oct 29, 2026EPS Estimate
21.88Next Dividend Ex-DateN/A
Dividend Yield4.09%
Share Statistics
EPS (TTM)39.11
Shares Outstanding256,142,670
10 Day Avg. Volume480,400
30 Day Avg. Volume536,760
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.91
Price to Sales (P/S)0.56
P/FCF Ratio128.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside3.77% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)128.08
Revenue Forecast (FY)¥610.06B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthMulti-year top-line growth supports a durable demand base across Daicel’s chemical and engineered-product businesses. Continued positive revenue in the latest annual period indicates customer programs and market reach remain intact despite weaker profitability.
Diversified End-Market ExposureExposure to functional chemicals, advanced materials and automotive safety components serves multiple industrial and consumer markets. This breadth can reduce reliance on one application and support recurring B2B demand from established customer programs.
Improved Balance SheetDebt-to-equity near 0.8x, down from above 1.0x, and higher equity provide more resilience than in prior periods. The improvement should support investment and reduce, though not eliminate, balance-sheet pressure through weaker cycles.
Bears Say
Profitability DeteriorationLatest-year net income fell sharply and operating profit compressed, showing that revenue growth is not converting reliably into earnings. Persistent margin pressure could constrain reinvestment and increase sensitivity to product mix and input costs.
Volatile Free Cash FlowOperating cash flow is generally positive, but free cash flow has been negative in some years and nearly breakeven most recently. Investment or working-capital demands may continue to limit internally funded growth and financial flexibility.
Meaningful Borrowing ExposureAlthough leverage improved, total debt remains sizable and borrowing remains a meaningful part of the capital structure. This can amplify earnings volatility and refinancing exposure if weaker margins persist across cyclical chemical and automotive markets.
Daicel News
4202 FAQ
What was Daicel’s price range in the past 12 months?
Daicel lowest stock price was ¥1112.50 and its highest was ¥1658.00 in the past 12 months.
What is Daicel’s market cap?
Daicel’s market cap is ¥373.57B.
When is Daicel’s upcoming earnings report date?
Daicel’s upcoming earnings report date is Oct 29, 2026 which is in 66 days.
How were Daicel’s earnings last quarter?
Daicel released its earnings results on Jul 30, 2026. The company reported ¥36.65 earnings per share for the quarter, beating the consensus estimate of ¥22.291 by ¥14.359.
Is Daicel overvalued?
According to Wall Street analysts Daicel’s price is currently Undervalued.
Does Daicel pay dividends?
Daicel pays a Semiannually dividend of ¥35 which represents an annual dividend yield of 4.09%. See more information on Daicel dividends here
What is Daicel’s EPS estimate?
Daicel’s EPS estimate is 21.88.
How many shares outstanding does Daicel have?
Daicel has 256,142,670 shares outstanding.
What happened to Daicel’s price movement after its last earnings report?
Daicel reported an EPS of ¥36.65 in its last earnings report, beating expectations of ¥22.291. Following the earnings report the stock price went up 0.035%.
Which hedge fund is a major shareholder of Daicel?
Currently, no hedge funds are holding shares in JP:4202
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daicel
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
4202 Stock 12 Month Forecast
Average Price Target
¥1,500.00
▲(3.77% Upside)
Technical Analysis
Kaneka
―
Mitsubishi Gas Chemical Company
―
UBE Industries
―
Zeon
―
Sumitomo Bakelite Co., Ltd.
―










